SLC7A7/LAT1 is a biomarker of superior immune infiltration (B cells, CD4+ and CD8+ T cells, DCs, macrophages, and neutrophils) and improved clinical outcomes in patients with non-small cell lung cancer (NSCLC) (24). This evidence concerns the gene SLC7A7 and non-small cell lung carcinoma.